Cases & Deals

  • Home
  • Practices
  • Advanced Cell Diagnostics develops patent portfolios related to assays and systems for in-situ multiplex detection and quantification of RNA molecules for diagnostic applications

Share

Advanced Cell Diagnostics develops patent portfolios related to assays and systems for in-situ multiplex detection and quantification of RNA molecules for diagnostic applications

November 2020

Client(s) Advanced Cell Diagnostics, Inc.

Jones Day represented Advanced Cell Diagnostics, Inc. in the development of global patent portfolios related to assays and systems for in-situ multiplex detection and quantification of RNA molecules and applications thereof for diagnosis.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.